Immunological Parameters in Patients Suffering from Atopic Dermatitis and Either Treated or Non-Treated with Dupilumab

CONCLUSION: We demonstrated the difference in the count of white blood cells populations in patients suffering from AD compared with healthy control. There were a differences in the expression of immunoregulatory molecules CD23 and CD200 on B cells in AD patients (either with or without dupilumab therapy) in comparison to healthy controls.PMID:37930093 | DOI:10.14712/18059694.2023.15

Source: Acta Medica: Hradec Kralove - November 6, 2023 Category: General Medicine Authors: Petra Boudkov á Jarmila Čelakovská Eva Čermáková Ctirad Andr ýs Jan Krejsek Source Type: research